Anti-anginal Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Anti-anginal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 212889-002 | Jan 28, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd Iii | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 212788-002 | May 5, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sciegen Pharms Inc | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211829-001 | Jun 4, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
I3 Pharms | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 213517-002 | Apr 27, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |